Carl L Gordon Keros Therapeutics, Inc. (KROS) insider trading activity

KROS Quotes by TradingView

Carl L Gordon is of Keros Therapeutics, Inc.. Currently has a direct ownership of 5,250 shares of KROS, which is worth approximately $79,327. The most recent transaction as insider was on Jun 04, 2025, when has been sold 5,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.25K
n/a 3M change
n/a 12M change
Total Value Held $79,327

CARL L GORDON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2025
BUY
Grant, award, or other acquisition
-
5,250 Added 50.0%
5,250 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
KNTE
Kinnate Biopharma Inc. Healthcare
Director
PRVL
Prevail Therapeutics Inc.
Director
TERN
Terns Pharmaceuticals, Inc. Healthcare
Director
ACET
Adicet Bio, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
Director
GMTX
Gemini Therapeutics, Inc. Healthcare
Director
THRX
Theseus Pharmaceuticals, Inc. Healthcare
Director
CMPX
Compass Therapeutics, Inc. Healthcare
Director
AVBP
ArriVent Biopharma, Inc.
Director
MBX
MBX Biosciences, Inc.
Director
CLG

Carl L Gordon

San Diego, CA

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS